Clinical Trial

A Study to Evaluate the Safety and Efficacy of NT-88

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
A study to evaluate the safety and preliminary efficacy of Zuozhu Daxi in patients with chronic heart failure with mildly reduced ejection fraction
Trial Details
NCT Number NCT07509801
Lead Sponsor Guangzhou Manjing biomedicine technology co., ltd
Conditions Heart Failure With Mildly Reduced Ejection Fraction
Enrollment 60 participants
Start Date 2026-03-30
Primary Completion 2027-02-25 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-03